Patent details

EP1831252 Title: GLP-1 ANALOG FUSION PROTEIN FORMULATIONS

Basic Information

Publication number:
EP1831252
PCT Application Number:
PCT/US/2005/045376
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP058541509
PCT Publication Number:
WO/2006/068910
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
GLP-1 ANALOG FUSION PROTEIN FORMULATIONS
French Title of Invention:
PREPARATIONS CONTENANT UNE PROTEINE HYBRIDE ANALOGUE DU GLP-1
German Title of Invention:
FORMULIERUNGEN GLP-1-ANALOGER FUSIONSPROTEINE
SPC Number:

Dates

Filing date:
15/12/2005
Grant date:
01/07/2009
EP Publication Date:
01/07/2009
PCT Publication Date:
29/06/2006
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
12/09/2007
EP B1 Publication Date:
01/07/2009
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
15/12/2011
Expiration date:
15/12/2025
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
15/12/2005
 
 

Name:
ELI LILLY AND COMPANY
Address:
Lilly Corporate Center, Indianapolis IN 46285, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
01/07/2009
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
GLAESNER Wolfgang
Address:
United States (US)

2

Name:
MILLICAN Rohn, Lee, Junior
Address:
United States (US)

Priority

Priority Number:
641690 P
Priority Date:
22/12/2004
Priority Country:
United States (US)

Classification

Main IPC Class:
C07K 14/50;
Filing date Document type Number of pages